Interleukin-22 fusion proteins, and their pharmaceutical compositions
US12240879B2 · kind B2 · utility
0Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2021 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Mar 28, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are a fusion protein comprising an interleukin-22 domain and an albumin binding domain, and a pharmaceutical composition thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of an inflammatory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.